We have located links that may give you full text access.
English Abstract
Journal Article
[Adipokines and the cardiorespiratory system in young patients with type 1 diabetes mellitus].
Terapevticheskiĭ Arkhiv 2022 November 23
UNLABELLED: Early screening of complications of diabetes mellitus (DM) is one of the priorities for public health. Most patients with type 1 diabetes mellitus (T1DM) are patients of working age. New strategies for the primary prevention of cardiovascular disease (CVD) are needed to prevent their early disability.
AIM: To assess the predictive value of adipokines in relation to a personalized approach to the need for an in-depth examination of young patients with T1DM.
MATERIALS AND METHODS: The study included 98 patients without CVD: 70 patients with T1DM (mean age 26.4±8.1 years) and 28 patients without DM (mean age 27±9 years). All patients underwent a general clinical examination, the levels of adipokines were determined, ergospirometry, echocardiography, and bioimpedancemetry were performed.
RESULTS: Changes in the cardiorespiratory system in patients with T1DM were revealed, in comparison with persons without T1DM: anaerobic threshold was reached faster ( p =0.001), maximum oxygen consumption was lower ( p =0.048), metabolic equivalent was reduced ( p =0.0001). Signs of myocardial remodeling were found in the T1DM group: there was an increase in the relative wall thickness ( p =0.001), the posterior wall of the left ventricle ( p =0.001), myocardial mass index ( p =0.049), in comparison with persons without T1DM. Changes in the adipokines system were revealed: higher levels of resistin ( p =0.002) and visfatin ( p =0.001), lower level of adiponectin ( p =0.040) in T1DM. A positive correlation was found between posterior wall of the left ventricle and visfatin ( p =0.014) and a negative relationship between adiponectin and relative wall thickness ( p =0.018) in T1DM.
CONCLUSION: In T1DM, even at a young age, there are multifactorial changes in the heart, which can be detected even at the preclinical stage. The data obtained can be used to identify groups of patients at high risk of developing dangerous CVD in T1DM, which can form the basis for determining the timing of the start of preventive therapy.
AIM: To assess the predictive value of adipokines in relation to a personalized approach to the need for an in-depth examination of young patients with T1DM.
MATERIALS AND METHODS: The study included 98 patients without CVD: 70 patients with T1DM (mean age 26.4±8.1 years) and 28 patients without DM (mean age 27±9 years). All patients underwent a general clinical examination, the levels of adipokines were determined, ergospirometry, echocardiography, and bioimpedancemetry were performed.
RESULTS: Changes in the cardiorespiratory system in patients with T1DM were revealed, in comparison with persons without T1DM: anaerobic threshold was reached faster ( p =0.001), maximum oxygen consumption was lower ( p =0.048), metabolic equivalent was reduced ( p =0.0001). Signs of myocardial remodeling were found in the T1DM group: there was an increase in the relative wall thickness ( p =0.001), the posterior wall of the left ventricle ( p =0.001), myocardial mass index ( p =0.049), in comparison with persons without T1DM. Changes in the adipokines system were revealed: higher levels of resistin ( p =0.002) and visfatin ( p =0.001), lower level of adiponectin ( p =0.040) in T1DM. A positive correlation was found between posterior wall of the left ventricle and visfatin ( p =0.014) and a negative relationship between adiponectin and relative wall thickness ( p =0.018) in T1DM.
CONCLUSION: In T1DM, even at a young age, there are multifactorial changes in the heart, which can be detected even at the preclinical stage. The data obtained can be used to identify groups of patients at high risk of developing dangerous CVD in T1DM, which can form the basis for determining the timing of the start of preventive therapy.
Full text links
Related Resources
Trending Papers
A Systematic Review of Subclinical Hyperthyroidism Guidelines: a Remarkable Range of Recommendations.European Thyroid Journal 2024 May 2
Nutrition in the intensive care unit: from the acute phase to beyond.Intensive Care Medicine 2024 May 22
2024 update in heart failure.ESC Heart Failure 2024 May 29
Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.Cochrane Database of Systematic Reviews 2024 May 22
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app